ASX:MDC Medlab Clinical (MDC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Medlab Clinical Stock (ASX:MDC) 30 days 90 days 365 days Advanced Chart Ad Chaikin AnalyticsTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. Get Medlab Clinical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume36,677 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.Read More… Tech funds are hemorrhaging cash: Sell this stock now (Ad)Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. Receive MDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter. Email Address MDC Stock News HeadlinesMedlab Clinical Faces Steep Revenue Decline and LossNovember 3, 2024 | markets.businessinsider.comChild Care on College Campuses: What to KnowOctober 24, 2024 | usnews.comTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. November 18, 2024 | Chaikin Analytics (Ad)Medlab West Africa - the Biggest Medical Lab Event in the Region Returns to LagosApril 16, 2024 | msn.comClinical Laboratory Technician SalaryMay 20, 2023 | money.usnews.comHealthKick Podcast: Aussie Bio Tech Medlab is confident in highly anticipated Phase III trialFebruary 13, 2023 | msn.comMEDLAB ANNOUNCES FAVOURABLE INTERIM READOUT OF NANABIS™ REAL-WORLD EVIDENCE (RWE) MEDCARE STUDYJanuary 12, 2023 | finance.yahoo.comInsights on the Virtual Clinical Trials Global Market to 2027 - Key Players Include Dassault Systemes, Medable, Science 37 and THREADDecember 28, 2022 | finance.yahoo.comSee More Headlines MDC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Medlab Clinical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryConstruction Current SymbolASX:MDC CUSIPN/A CIKN/A Webwww.medlab.co Phone61 2 8188 0311FaxN/AEmployees1,640Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($547.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,940,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-326.89% Return on Assets-79.67% Debt Debt-to-Equity Ratio28.56 Current Ratio0.35 Quick Ratio3.71 Sales & Book Value Annual Sales$-1,470,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.12 Book ValueA($0.31) per share Price / BookN/AMiscellaneous Outstanding Shares2,280,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.89 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (ASX:MDC) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medlab Clinical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Medlab Clinical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
